+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Establishment and characterization of a novel cancer cell line (SMOV-1), derived from the ascitic fluid of a woman with ovarian cancer who had never responded to chemotherapeutic drugs



Establishment and characterization of a novel cancer cell line (SMOV-1), derived from the ascitic fluid of a woman with ovarian cancer who had never responded to chemotherapeutic drugs



International Journal of Clinical Oncology 3(2): 108-112



Background: A novel cell line, designated SMOV-1, was established from the ascitic fluid of a woman with ovarian cancer. This report describes the process of establishment and characterization of this cell line. Methods: The case involved a woman who had undergone a surgical intervention, due to a serous papillary adenocarcinoma of the ovary. She received the combination chemotherapy of PAC (cisplatin + doxorubicin + cyclophosphamide) 6 times after the surgery. However, as a result of malignant pleural effusion during chemotherapy, she died 7 months after surgery. Before surgery, ascitic fluid was removed from the patient for cell culture, after obtaining her consent. The cells were successfully subcultured, and designated SMOV-1. Results: The cell line gave a pavement-stone pattern, without contact inhibition. SMOV-1 could also be transplanted into nude mice, and the tissue showed reconstruction of the original tumor. The chromosome number of the SMOV-1 cells was 57, and the DNA index was 2.28. The population-doubling time of the SMOV-1 cells was 61.4 hours. Cultured SMOV-1 cells were still capable of producing the tumor-associated antigens CA 125, CA 19-9, and sTn (sialosyl-Tn). Conclusion: We propose that this novel cell line is of possible use for the investigation of drug resistance in ovarian cancer.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 008623233

Download citation: RISBibTeXText

DOI: 10.1007/bf02492857


Related references

Establishment and characterization of a cancer cell line derived from ascitic fluid in a woman with ovarian cancer. Acta Cytologica 42(2 Suppl. ): 490, March-April, 1998

Establishment and characterization of human ovarian clear cell adenocarcinoma cell line (SMOV-2), and its cytotoxity by anticancer agents. Human Cell 12(3): 139-148, 1999

Establishment and characterization of an IGSK-2 cell line derived from ascitic fluid of recurrent hCG and somatostatin secreted adenocarcinoma of the stomach. Human Cell 20(2): 52-61, 2007

Establishment and characterization of a human ovarian small cell carcinoma, hypercalcemic type, cell line (OS-1) secreting PTH, PthrP and ACTH--special reference to the susceptibility of anti-cancer drugs. Human Cell 17(4): 203-209, 2004

Establishment and characterization of the rhabdomyosarcoma cell line designated NUTOS derived from the human tongue sarcoma: Special reference to the susceptibility of anti-cancer drugs. Human Cell 23(2): 65-73, 2010

Establishment and characterization of human cancer cell line (NOC-S) derived from a progressive lung cancer. Human Cell 3(2): 158-162, 1990

Ascitic fluid from advanced ovarian cancer patients compromises the activity of receptor tyrosine kinase inhibitors in 3D cell clusters of ovarian cancer cells. Cancer Letters 420: 168-181, 2018

Ascitic fluid from advanced ovarian cancer patients compromises the activity of receptor tyrosine kinase inhibitors in 3D cell clusters of ovarian cancer cells. Cancer Letters 420: 168-181, 2018

Establishment and Characterization of a Highly Metastatic Ovarian Cancer Cell Line. Biomed Research International 2018: 3972534, 2018

Establishment of a highly metastatic human ovarian cancer cell line (HO-8910PM) and its characterization. Journal of Experimental and Clinical Cancer Research 18(2): 233-239, 1999

Establishment and characterization of human ovarian cancer cell line undifferentiated carcinoma figo. Archives of Gynecology 237(Suppl.): 318, 1985

Establishment and Characterization of the Novel High-Grade Serous Ovarian Cancer Cell Line OVPA8. International Journal of Molecular Sciences 19(7):, 2018

Establishment and characterization of a cell line, EH-GB2, derived from hepatic metastasis of gallbladder cancer. Oncology Reports 27(3): 775-782, 2012

Establishment of a cell line from human ovarian cancer (undifferentiated carcinoma of FIGO classification) and analysis of its cell-biological characteristics and sensitivity to anticancer drugs. Nihon Sanka Fujinka Gakkai Zasshi 38(10): 1747-1753, 1986

Metabolomic characterization of experimental ovarian cancer ascitic fluid. Metabolomics 13:, 2017